VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹854 Cr | ₹716 Cr | ₹627 Cr | ₹601 Cr | ₹579 Cr |
What is the latest Total Liabilities ratio of VENUS REMEDIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹854 Cr |
| Mar2025 | ₹716 Cr |
| Mar2024 | ₹627 Cr |
| Mar2023 | ₹601 Cr |
| Mar2022 | ₹579 Cr |
How is Total Liabilities of VENUS REMEDIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹854 Cr | 19.28 | |
| Mar2025 | ₹716 Cr | 14.18 | |
| Mar2024 | ₹627 Cr | 4.28 | |
| Mar2023 | ₹601 Cr | 3.79 | |
| Mar2022 | ₹579 Cr | - | |
Compare Total Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,327.6 Cr | 12.3% | -8.1% | 232.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 12.3% |
-8.1% |
232.1% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses